(3-(n-Cyclohexylsulfamoyl)phenyl)boronic acid, 97%, 1g

2-Methyl-6-(trifluoromethyl)pyrimidin-4-ol, 95.0%, 5g

4-Iodo-1,3-dihydro-2H-indol-2-one, 95.0%, 250mg

Bis(dibenzylideneacetone)palladium(0), 98.0%, 250mg

[1,1':3',1''-Terphenyl]-4,4''-diol, 97%, 100mg

5-OXASPIRO[3.5]NONAN-8-OL, 95.0%, 1g

4-(4-Fluorophenyl)pyridine-2-carboxylic acid, 97.0%, 1g

(2R,3S)-2-((R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholine hydrochloride, 97%, 10g

3,4-Diethoxycyclobut-3-ene-1,2-dione, 97.0%, 25g

Acide nitrilotriacétique, min 99%, ultra pur, 100 g, emballage plastique.

Methyl 4-oxopiperidine-1-carboxylate, 95.0%, 250mg

1-(BROMOMETHYL)-1-METHYLCYCLOPENTANE, 95.0%, 250mg

Phenyl(2-thioxothiazolidin-3-yl)methanone, 97%, 1g